摘要
Metabolic syndrome-associated steatotic liver disease(MASLD)has become the main driver of liver morbidities,and recently prevalence has risen over 30%.20%-30%of patients develop chronic inflammation and progress to metabolic-associated steatohepatitis(MASH),which is becoming the leading cause of cirrhosis and hepatocellular carcinoma(HCC)[1,2].MASLD is a complex disease where severity is dependent on several factors,including lifestyle,genetics,diet but also iron metabolism.
作者简介
Corresponding author:Luca Valenti,E-mail address:luca.valenti@unimi.it。